2008 Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice

上传人:麦**** 文档编号:141787213 上传时间:2020-08-12 格式:PDF 页数:11 大小:2.41MB
返回 下载 相关 举报
2008 Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice_第1页
第1页 / 共11页
2008 Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice_第2页
第2页 / 共11页
2008 Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice_第3页
第3页 / 共11页
2008 Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice_第4页
第4页 / 共11页
2008 Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice_第5页
第5页 / 共11页
点击查看更多>>
资源描述

《2008 Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice》由会员分享,可在线阅读,更多相关《2008 Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice(11页珍藏版)》请在金锄头文库上搜索。

1、Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice Marta L. DeDiego a, Lecia Peweb, Enrique Alvareza, Maria Teresa Rejasc, Stanley Perlmanb, Luis Enjuanesa, a Department of Molecular and Cell Biology, Centro Nacional de Biotecnologa (CSIC), Campus Univer

2、sidad Autnoma, Darwin 3, Cantoblanco, 28049 Madrid, Spain b Department of Microbiology, University of Iowa, Iowa City, Iowa 52242, USA c Centro de Biologa Molecular (CSIC-UAM), Facultad de Ciencias, Campus Universidad Autnoma, Cantoblanco, 28049 Madrid, Spain a r t i c l ei n f oa b s t r a c t Arti

3、cle history: Received 17 January 2008 Returnedtoauthorforrevision21February2008 Accepted 10 March 2008 Available online 2 May 2008 Recombinant severe acute respiratory virus (SARS-CoV) variants lacking the group specifi c genes 6, 7a, 7b, 8a, 8b and 9b (rSARS-CoV-69b), the structural gene E (rSARS-C

4、oV-E), and a combination of both sets of genes (rSARS-CoV-E,69b) have been generated. All these viruses were rescued in monkey (Vero E6) cells and were also infectious for human (Huh-7, Huh7.5.1 and CaCo-2) cell lines and for transgenic (Tg) mice expressing the SARS-CoV receptor human angiotensin co

5、nverting enzyme-2 (hACE-2), indicating that none of these proteins is essential for the viral cycle. Furthermore, in Vero E6 cells, all the viruses showed the formation of particles with the same morphology as the wt virus, indicating that these proteins do not have a high impact in the fi nal morph

6、ology of the virions. Nevertheless, in the absence of E protein, release of virus particles effi cacy was reduced. Viruses lacking E protein grew about 100-fold lower than the wt virus in lungs of Tg infected mice but did not grow in the brains of the same animals, in contrast to the rSARS-CoV-69b v

7、irus, which grew almost as well as the wt in both tissues. Viruses lacking E proteinwere highly attenuated in the highlysensitive hACE-2 Tg mice, in contrast tothe minimal rSARS-CoV-69b and wt viruses. These data indicate that E gene might be a virulence factor infl uencing replication level, tissue

8、 tropism and pathogenicity of SARS-CoV, suggesting that E attenuated viruses are promising vaccine candidates. 2008 Elsevier Inc. All rights reserved. Keywords: Coronavirus SARS-CoV hACE-2 transgenic mice Introduction The etiologic agent causing severe acute respiratory syndrome (SARS) is a novel co

9、ronavirus (CoV) named SARS-CoV (Drosten et al., 2003; Fouchier et al., 2003; Ksiazek et al., 2003; Kuiken et al., 2003; Marra et al., 2003; Peiris et al., 2003; Rota et al., 2003). The disease, which caused an average mortality of approximately 10% and for which no defi ned therapy is available, was

10、 reported for the fi rst time in Guandong province, China, at the end of 2002, and rapidlyspread to 32 countries. After July 2003, only four community acquired cases were reported in China, although there have been three instances of laboratory-acquired infections described (http:/www.who.int/csr/ s

11、ars/en/). Initial investigations indicated that SARS-CoV spread to humans from infected wild animals in wet markets of Southern China, such as Himalayan palm civets (Paguna larvatta) and Chinese ferret badgers (Melogale moschatta) (Guan et al., 2003). Nevertheless, the recognition of SARS-like CoVs

12、in bats suggests that these species are most likely the natural reservoir of SARS-CoV (Lau et al., 2005; Li et al., 2005). Therefore, the reemergence of the virus remains a possibility and the engineering of attenuated viruses as research tools and vaccine can- didates is of high interest. SARS-CoV

13、is an enveloped virus of the Coronaviridae family, and hasa single-stranded, positive sense29.7 kb RNAgenome (Gorbalenya et al., 2004; Snijder et al., 2003). Human coronaviruses have been divided into different groups (Enjuanes et al., 2008b). Group 1 in- cludes the human coronavirus 229E (HCoV-229E

14、), generally asso- ciated with the common cold, and HCoV-NL63, which causes more severe lower respiratory diseases (Fouchier et al., 2004; Kaiser et al., 2005; van der Hoek et al., 2004). Group 2 human CoVs include HCoV- OC43, which has been associated with common colds, the recently described HCoV-

15、HKU1, which was identifi ed in adults with pneumo- nia (Woo et al., 2005), and SARS-CoV. Among human CoVs, SARS-CoV causes the most severe disease (Weiss and Navas-Martin, 2005). Coronaviruses replicate in the cell cytoplasm and encode a nested set of mRNA molecules of different sizes. Viral genome

16、expression begins with the translation of two large polyproteins, pp1a and pp1ab, including the viral replicase genes (Thiel et al., 2003). These genes are involved in genome replication and transcription of subgenomic mRNAs (sg mRNAs), encoding structural proteins such as the spike (S), envelope (E), membrane (M), andnucleocapsid (N),anda setofgroup- specifi c proteins, whose sequence and number differs among the different species of coronavirus (Enjuanes et al., 2008b). In the case of SARS-C

展开阅读全文
相关资源
相关搜索

当前位置:首页 > 研究生/硕士 > 专业课

电脑版 |金锄头文库版权所有
经营许可证:蜀ICP备13022795号 | 川公网安备 51140202000112号